Biotech startup nets $3.4M to advance treatments for MRSA, salmonella bacterial infections Posted on December 7, 2013 by henrykotula • Posted in Uncategorized • Tagged Biotech, Life Sciences, MRSA, Startup • Leave a comment Biotech startup nets $3.4M to advance treatments for MRSA, salmonella bacterial infections Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading... Related
HENRY KOTULA 